Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

紫杉醇口服溶液 - NMPA Drug Approval Details

Approvals/NMPA/Paclitaxel Oral Solution

Approved

化学药品

Paclitaxel Oral Solution

DAEHWA PHARMACEUTICAL CO.,LTD.🇨🇳 National Medical Products Administration

Approval Date: Sep 19, 2024
Approval ID: 8dGWHg7gdod
Company: DAEHWA PHARMACEUTICAL CO.,LTD.
Type: 化学药品

Approval Details

Approval Id: 8dGWHg7gdod
Approval Number: 国药准字HJ20240096
Generic Name: 紫杉醇口服溶液
Generic Name En: Paclitaxel Oral Solution
Drug Type: 化学药品
Dosage Form: 口服溶液剂
Strength: 5ml:50mg
Reg Date: 2024-09-19
Expired Date: 2029-09-18
Company Name: DAEHWA PHARMACEUTICAL CO.,LTD.
Production Company Name: DAEHWA PHARMACEUTICAL CO.,LTD.
Company Detail Path: /organization/daehwa-pharmaceutical-co-ltd
Production Company Detail Path: /organization/daehwa-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 19, 2024

Approval ID

8dGWHg7gdod

Type

化学药品

Back to NMPA Approvals